Tumor inflammation could lead to an antitumor immunity deficiency by involving T-helpers and T-regulating lymphocytes, notably via immune checkpoints (PD1–PDL1, CTLA4) and cytokines [33,34], thus promoting tumor growth. This evidence concerns the gene CD274 and neoplasm.